NEWS RELEASE
FEBRUARY 22, 2007
  28-Year Old Penn Patient, Undergoing Treatment for Deadly Brain Tumor, Stresses Importance of Clinical Trials
Back to Article
Image    1
   

Cotara, a monoclonal antibody that targets the DNA of cancer cells and carries a radioactive isotope, is delivered through a method called convection enhanced delivery (CED), which uses a catheter to bypass the blood-brain barrier and target the specific tumor site in the brain.

Image Courtesy: Peregrine Pharmaceuticals, Inc.

Delivery of Cotara to Brain Tumor Site
 


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2013, The Trustees of the University of Pennsylvania